<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="22710">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on April 10, 2017</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02811146</url>
  </required_header>
  <id_info>
    <org_study_id>54735716.3.0000.5208</org_study_id>
    <nct_id>NCT02811146</nct_id>
  </id_info>
  <brief_title>Cardiac Rehabilitation and Noninvasive Ventilation in Heart Failure</brief_title>
  <sponsors>
    <lead_sponsor>
      <agency>Universidade Federal de Pernambuco</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Universidade Federal de Pernambuco</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The study aims to demonstrate the efficacy of NIV continuously in cardiac rehabilitation
      programs, improvement of exercise tolerance, with consequent reflection in functional
      capacity and quality of life of this population.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      BACKGROUND: Heart failure (HF) is a cardiovascular syndrome with enormous impact on public
      health by high morbidity and mortality rates that are associated. Studies show that changes
      in striated skeletal muscle of those individuals, possibly caused by progressive physical
      inactivity, contribute to the construction of the pathophysiology of this disease,
      emphasizing the importance of exercise for these patients. Exercise programs can be traced
      safer and related form the actual functional capacity thereof. Cardiac rehabilitation it is
      a set of activities that aims to ensure that patients with heart disease the best
      conditions, especially physical. In this context, non-invasive ventilation (NIV) is an
      alternative to provide an improved tolerance during exercise in patients with HF.

      GOALS: Evaluate the effectiveness of the use of NIV association to aerobic exercise in
      exercise programs supervised during cardiac rehabilitation exercise tolerance and quality of
      life in patients with heart failure when compared to performing these exercises without
      ventilatory support.

      METHODS: This is a clinical trial, controlled, randomized and blind to be developed with
      patients arising out of the main Recife reference centers in the care of patients with heart
      failure. It will be conducted assessments of functional capacity made by cardiopulmonary
      exercise testing (CPET), the Glittre-ADL test and through the questionnaire Duke Activity
      Status Index (DASI), assessment of quality of life using the questionnaire Minnesota Living
      with Heart Failure (MLWHF), and finally, in order to determine a clinical change, will be
      used to Patient Global Impression of Change Scale (PGIS).

      EXPECTED RESULTS: This study aims to demonstrate the efficacy of NIV continuously in cardiac
      rehabilitation programs, improvement of exercise tolerance, with consequent reflection in
      functional capacity and quality of life of this population.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>July 2016</start_date>
  <completion_date type="Anticipated">December 2017</completion_date>
  <primary_completion_date type="Anticipated">June 2017</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single Blind (Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Cardiopulmonary exercise testing</measure>
    <time_frame>Baseline and 12 weeks</time_frame>
    <description>Change in functional capacity</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Glittre-ADL Test</measure>
    <time_frame>Baseline and 12 weeks</time_frame>
    <description>Change in submaximal functional capacity</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Minnesota Living with Heart Failure</measure>
    <time_frame>Baseline and 12 weeks</time_frame>
    <description>Improved in quality of life</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Bioimpedance scale</measure>
    <time_frame>Baseline and 12 weeks</time_frame>
    <description>Change in the body composition</description>
  </secondary_outcome>
  <number_of_arms>5</number_of_arms>
  <enrollment type="Anticipated">30</enrollment>
  <condition>Heart Failure</condition>
  <arm_group>
    <arm_group_label>Cardiopulmonary exercise testing</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Assess whether people who wore noninvasive ventilation during aerobic exercise have greater functional capacity than those who did not wear.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>ADL Glitre test</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Check that people who wore noninvasive ventilation during aerobic exercise have greater submaximal functional capacity than those who did not wear.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Ultrasonography of the diaphragm muscle</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>See if people who wore noninvasive ventilation during aerobic exercise have greater mobility and diaphragmatic thickness than those who did not wear.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Minnesota Living with Heart Failure</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Check if people undergoing heart rehabilitation has improved quality of life.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Bioimpedance balance</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Check if people undergoing heart rehabilitation has improved the body composition.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Bilevel Positive Pressure Airway</intervention_name>
    <description>Heart rehabilitation with noninvasive ventilation, for 12 weeks, 3 times a week</description>
    <arm_group_label>Cardiopulmonary exercise testing</arm_group_label>
    <arm_group_label>ADL Glitre test</arm_group_label>
    <arm_group_label>Ultrasonography of the diaphragm muscle</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Heart rehabilitation</intervention_name>
    <description>Heart rehabilitation, for 12 weeks, 3 times a week</description>
    <arm_group_label>Cardiopulmonary exercise testing</arm_group_label>
    <arm_group_label>ADL Glitre test</arm_group_label>
    <arm_group_label>Ultrasonography of the diaphragm muscle</arm_group_label>
    <arm_group_label>Minnesota Living with Heart Failure</arm_group_label>
    <arm_group_label>Bioimpedance balance</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Sedentary adults diagnosed with heart failure of ischemic hypertensive or alcoholic
             etiology;

          -  Ejection fraction of the left ventricle smaller than 45% (LVEF &lt;45%) assessed by
             echocardiography simple;

          -  Recent and functional class II and III by the New York Heart Association (NYHA);

          -  FEV1 &lt;80% predicted and / or FEV1 / FVC&gt; 70% predicted;

          -  Clinical stability; Ex-smokers for more than five years;

          -  No change in the class of drugs within three months prior to the beginning of the
             study.

        Exclusion Criteria:

          -  Patients with unstable angina;

          -  Myocardial infarction or heart surgery up to three months before the survey;

          -  FEV1 / FVC &lt;70% predicted characterizing obstructive respiratory disorder;

          -  Respiratory diseases;

          -  Smoking;

          -  Hemodynamic instability;

          -  Trauma of recent face;

          -  Nausea and vomiting;

          -  Orthopedic and neurological diseases;

          -  Psychic changes that restrict them to respond to the questionnaire.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>21 Years</minimum_age>
    <maximum_age>60 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Bruna Thays Araújo</last_name>
    <phone>997961625</phone>
    <email>brunathays.araujo@gmail.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Cardiopulmonary Physiotherapy Laboratory</name>
      <address>
        <city>Recife</city>
        <state>Pernambuco</state>
        <zip>50740-560</zip>
        <country>Brazil</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>DANIELLA BRANDÃO</last_name>
      <phone>81981359335</phone>
      <email>daniellacunha@hotmail.com</email>
    </contact>
    <contact_backup>
      <last_name>JÉSSICA LEITE</last_name>
      <phone>83988667323</phone>
      <email>jcl.15@hotmail.com</email>
    </contact_backup>
    <investigator>
      <last_name>BRUNA ARAÚJO</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hospital of the Clinics Federal University of Pernambuco</name>
      <address>
        <city>Recife</city>
        <state>PE</state>
        <zip>50670-901</zip>
        <country>Brazil</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>BRUNA THAYS S DE ARAÚJO</last_name>
      <phone>81997961625</phone>
      <email>brunathays.araujo@gmail.com</email>
    </contact>
    <contact_backup>
      <last_name>JÉSSICA LEITE</last_name>
      <phone>83988667323</phone>
      <email>jcl.15@hotmail.com</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>Brazil</country>
  </location_countries>
  <verification_date>November 2016</verification_date>
  <lastchanged_date>January 3, 2017</lastchanged_date>
  <firstreceived_date>June 2, 2016</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Universidade Federal de Pernambuco</investigator_affiliation>
    <investigator_full_name>BRUNA THAYS SANTANA DE ARAÚJO</investigator_full_name>
    <investigator_title>physiotherapist, clinical research</investigator_title>
  </responsible_party>
  <keyword>Heart Failure</keyword>
  <keyword>Noninvasive Ventilation</keyword>
  <keyword>Positive- Pressure Respiration</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Heart Failure</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
